Glycomimetics Inc. Stock
Price
Target price
€0.14
€0.14
-3.950%
-0.0058
-3.950%
€9.13
10.09.24 / Tradegate
WKN: A1W8HZ / Symbol: GLYC / Name: GlycoMimetics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Glycomimetics Inc. Stock
Glycomimetics Inc. took a tumble today and lost -€0.006 (-3.950%).
Our community is currently low on Glycomimetics Inc. with 3 Buy predictions and 8 Sell predictions.
On the other hand, the target price of 9 € is above the current price of 0.14 € for Glycomimetics Inc., so the potential is actually 6115.47%.
So far the community has only identified positive things for Glycomimetics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Glycomimetics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Glycomimetics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Glycomimetics Inc. | -3.950% | -6.821% | -15.519% | -89.568% | -93.593% | -92.379% | -96.198% |
| Ardelyx Inc. | 4.070% | 1.374% | -0.997% | 20.373% | -10.657% | 341.368% | -5.698% |
| Evolus Inc | 6.250% | -8.571% | 11.304% | 42.222% | 41.436% | 77.778% | - |
| Coherus Bioscien. | -2.110% | 0.855% | -5.134% | -72.940% | -59.276% | -90.550% | -93.150% |
Comments
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat